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The aim of  this study was to compare the effects of  different premedication protocols 
followed by a propofol/fentanyl TIVA on cardio-respiratory and hemodynamic changes 
in twenty-four dogs randomly divided into two groups (AMD-group: medetomidine, 
atropine and diazepam; AXD-group: xylazine, atropine and diazepam). Cardio-
respiratory variables, acid-base indices, quality of  sedation, induction, intubation and 
recovery were recorded throughout the experiment. 
Signifi cant changes were observed for the pO2 level, which was increased in the AMD- 
group from 90 min. (*P< 0.05) to 120 min. (**P< 0.01) of  anesthesia. This can be 
explained by a reduction of  the administration rate of  propofol/fentanyl TIVA and 
oxygenation initiated due to excessively deep anesthesia detected by an anesthetsiologist, 
leading to improved  ventilation and increased  pO2. The pCO2 (*P < 0.05) reached 
more preferable values during the fi rst 30 min. and pH (**P< 0.01) was signifi cantly 
improved within the fi rst 60 min. in the AXD-group thanks to less depressant effects 
of  xylazine. Within the fi rst 30 min. of  anesthesia a signifi cant heart rate difference 
between the groups was accompanied with signifi cantly higher BP (hypertension) in the 
AXD-group (10 min. ***P< 0.001, 30 min. **P< 0.01). This points to the possibility 
of  atropine application only in the case of  a tendency to bradycardia followed by 
hypotension.
It can be concluded that xylazine is a better option for the premedication of  a propofol/
fentanyl TIVA in dogs undergoing a prolonged surgical intervention, in spite of  the fact 
that lower sedation scores were attained. We have detected signifi cantly less adverse 
cardio-respiratory and hemodynamic effects of  xylazine, and a shorter recovery time 
when compared to medetomidine. 




Surgical interventions in animals requiring general anesthesia are routinely maintained 
via inhalation of  volatile anesthetic agents, however there are some contraindications 
(such as gastoresophageal refl ux or epilepsy) which can limit their usage. For these 
reasons, a total intravenous anesthesia (TIVA) could provide a suitable alternative to 
this method, mostly, but not only when short surgical anesthesia is required, because 
various combinations of  drugs at different doses can be administered [1, 2]. The 
integral part of  the perioperative management is also the administration of  antibiotics 
[3]. Different degrees of  sophistication of  TIVA, from simple continuous to target 
controlled infusions, are used in veterinary practice. Nevertheless, the general principle 
of  TIVA is to control the infusion rates of  drugs, thus allowing the regulation of  their 
concentrations in the blood with regard to undesirable responses of  the anesthetized 
patients (e.g.: pain, awakening) during surgical procedures.
Different anesthetic protocols for the premedication, induction and maintenance 
of  general anesthesia using the TIVA have been applied in dogs. It is obvious that 
propofol is the drug of  choice for TIVA and it is applied mostly in combination with 
an analgesic agent, such as fentanyl, which provides a suffi cient degree of  analgesia 
required for surgical interventions as reviewed by Smith et al. [4]. The combination 
of  both these drugs is recommended for TIVA due to their quick metabolism and 
rapid elimination from the body [5]. Furthermore, it has been demonstrated that the 
metabolism of  propofol can be inhibited by fentanyl [6], but little is known about the 
interactions between different drugs so far. For these reasons, an appropriate selection 
of  agents used for premedication and anesthesia, with suitable pharmacokinetic and 
pharmacodynamic properties, as well as adequate dosage can signifi cantly improve 
intraoperative cardiovascular stability, perioperative analgesia and the quality of  
recovery [7].
Therefore, this study was conducted to evaluate the impact of  medetomidine, atropine 
and diazepam premedication or xylazine, atropine and diazepam premedication on 
total intravenous anesthesia induced and maintained with propofol/fentanyl on the 




Twenty-four dogs were randomly divided into two experimental groups with different 
premedication protocols (AMD-group: n = 12 – medetomidine (Cepetor, CP Pharma, 
Germany) + atropine (ATROPINE, Biotika, Slovak Republic) + diazepam (Apaurin, 
KRKA, Slovenia); XMD-group: n = 12 – xylazine (Rometar, Bioveta, Slovak Republic) 
+ atropine + diazepam). Based on ASA Physical Status Classifi cation System [8], all 
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dogs were considered to be suitable for surgery (such as: castration, ovariohysterectomy, 
cranial cruciate ligament surgery, endodontic and orthodontic treatment). The study 
was approved by the local Ethics Committee. The owners were fully informed and 
agreed with the anesthetic protocol.
Experimental design
Food was withheld for 12 hours prior to anesthesia, but dogs had free access to water. 
Following the placement of  the catheters into the v. saphena dextra for a propofol/
fentanyl constant rate infusion total intravenous anesthesia (P/F TIVA) and into the 
v. cephalica antebrachii dextra for blood sampling, premedication was performed using 
intravenous (i.v.) medetomidine (M) or i.v. xylazine (X) at doses of  0.02 mg/kg and 
0.7 mg/kg, respectively, in combination with atropine (A, dose 0.02 mg/kg i.v.) and 
diazepam (D, dose 0.5 mg/kg i.v.).  After recording the sedation score (5, 10, 15 
min.), i.v. propofol (Propofol, Fresenius Kabi, Germany; dose 2 mg/kg) and fentanyl 
(Fentanyl TORREX, Chiesi Pharmaceuticals, Austria; dose 2 μg/kg) were used for the 
induction of  anesthesia. Intubation was performed and subsequently the dogs were 
placed in a left recumbent position. Immediately after positioning, an i.v. infusion of  
propofol/fentanyl mixture at doses of  0.2 mg/kg per min. and 0.2 μg/kg per min. 
was started and maintained throughout the P/F TIVA by an infusion system IPB 2050 
(Polymed, CZ). Subsequently, the patient was prepared for the surgical procedure. 
Small boluses of  propofol (1 mg/kg i.v.) or fentanyl (1 μg/kg i.v.) should have been 
applied when inadequate anesthesia was recorded (muscle movements in response 
to surgical stimulation). When the anesthesiologist found an excessive depth of  
anesthesia, based on the palpebral and corneal refl ex, position of  the eyeball and size 
of  the pupils, the infusion rate was reduced to 0.1 mg of  propofol/kg per min. and 0.1 
μg of  fentanyl/kg per min. The occurrence of  apnea for a period longer than 20-30 
sec. was indicative for an intermittent positive pressure ventilation and discontinuation 
of  the propofol and fentanyl infusion. These dogs were ventilated 1-1.5 min. until 
spontaneous ventilation was restored and RR increased up to 6 breaths per minute. 
Preanesthetic sedation, induction and endotracheal intubation scales [9] were used to 
assess the sedation score during premedication at the 5th, 10th and 15th min. (-15, 
-10, -5, respectively), and after induction and intubation, respectively. At the end of  
the P/F TIVA, all dogs laying in a lateral recumbency were placed in the recovery 
room. During the recovery, each dog was observed independently by an experienced 
anesthesiologist to examine four criteria as follows: time to extubation, time to head 
lift, time to sternal recumbency, and time to standing without assistance. In addition, 
the recovery period of  each dog was evaluated until the decision on the fi nal recovery 
score following anesthesia according to Jiménez [10] was confi rmed. 
Sample and data collection and their analyses
Before the premedication (C – baseline values), and immediately at the beginning of  
the P/F TIVA (0), at 10 min. intervals for 2 hours (10, 20, 30, 40, 50, 60, 70, 80, 
Lipták et al.
469
90, 100, 110, 120), and after the P/F TIVA at the time when the dogs were able to 
stand without assistance (POST), the heart rate (HR, heart beats per min.), respiratory 
rate (RR, breaths per min.), systolic (SBP, mmHg), diastolic (DBP, mmHg) and mean 
(MBP, mmHg) blood pressures were recorded on the left thoracic limb by a Patient 
Monitor-9000Vet (Hamburg, DE). The blood pressures were measured only during 
the P/F TIVA, when the dogs were not able to resist the restraint. In addition, at C, 
0, 30, 60, 90, 120 min, the blood was collected into heparinized capillary test tubes to 
determine the acid-base balance. Immediately after collection, the blood samples were 
analyzed by a blood acid-base analyzer ABL5 (Radiometer Copenhagen, DEN).
Statistical analyses
The results are presented as mean values ± standard deviation. As comparing both 
groups, statistical analysis of  the same indices in a row was done using the paired 
Student’s t-test (*P<0.05, **P<0.01, ***P<0.001). Within the same group, except for 
SBP, MBP and DBP, all indices were compared to C using a one-way ANOVA with the 
Dunnet´s post-test (aP<0.05, bP<0.01).
RESULTS
When comparing the experimental groups, AMD vs. XMD the following sedation 
scores (-15: 3.0±0.6 vs 2.0±0.4; -10: 3.8±0.5 vs 2.4±0.5;  -5: 4.2±0.4 vs. 3.1±0.3), 
anesthetic induction scores (1.1±0.3 vs 1.2±0.4), and endotracheal intubation scores 
(1.0±0.0 vs. 1.3±0.5) were observed.
Changes of  the hemodynamic indices are summarized in Table 1. In both groups, 
pH started to fall at 0 (7.29 ±0.06b vs. 7.35±0.03a, **P<0.01) and was signifi cantly 
decreased until the end of  the P/F TIVA when compared to C. The AMD-group 
showed a more signifi cant alteration of  pH within the 1st hour of  the P/F TIVA 
due to more observable depressant effects of  medetomidine. (AMD/0: 7.29 ±0.06, 
AXD/0: 7.35±0.03, **P < 0.01; AMD/30: 7.2±0.08, AXD/30: 7.27 ±0.03, *P<0.05; 
AMD/60: 7.17±0.09, AXD/60: 7.2 ±0.03, *P<0.05).
At 30 min., signifi cantly increased pCO2 was found in the AMD-group (8.03 ±1.53
b vs 
6.63 ±0.74b, **P < 0.01) and pO2 was signifi cantly increased in the AMD-group from 
90 (9.68 ±2.67a vs 7.18 ±2.38b, *P < 0.05) to 120 min. (10.9 ±4.08 vs 6.9 ±2.71, **P 
< 0.01). This can be explained by a reduction of  the rate of  propofol/fentanyl TIVA 
administration and oxygenation initiated due to an excessively deep anesthesia detected 
by an anesthesiologist, leading to an improvement in the ventilation and an increase in 
pO2. In both groups, HCO3 was relatively stable, but SBC and BE were found to be 
signifi cantly decreased when compared to C. There were no signifi cant differences in 
these indices between the treatments. In both groups, the changes induced by the P/F 
TIVA were counterbalanced at POST. 
Changes in HR, RR, SBP, MBP and DBP are presented in Table 2. When comparing 
the groups, HR started to fall earlier (at 10) in the AMD-group (at 70 in the XMD-
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group), and RR decreased immediately at the beginning of  the P/F TIVA in both 
groups. Moreover, at the beginning of  the P/F TIVA, the value of  BP was signifi cantly 
lower in the AMD-group when compared with the AXD-group (SBP:AMD 162± 
30, AXD 202±18, MBP:AMD 113±26, AXD 156±16, ***P<0.001; DBP:AMD 
97±22, AXD 133±18, ***P<0.001), pH (7.29±0.06b vs 7.35±0.03a, **P<0.01). The 
initial hypertension was caused by increased HR, respectively by premedication with 
atropine and vasoconstriction caused by alpha - 2 agonists. It is noticeable that within 
the 1st hour of  the P/F TIVA, HR, RR SBP, MBP and DBP have a tendency to 
decrease more severely in the AMD-group, but then (except for RR) both groups 
leveled in regard to the cardio-respiratory parameters. Except for spontaneous blinking 
in response to surgical stimulation seen in both groups throughout the P/F TIVA, 
apnea was recorded in fi ve dogs in the AMD-group. Changes in the acid-base balance 
during anesthesia were not signifi cant compared to the dogs without apnea.   
Statistical differences between the AXD-group and the AMD-group (Table 3) 
were recorded for the shorter time to extubation (9±3 vs 13±5, *P<0.05), sternal 
recumbency (29±11 vs 39±11, *P<0.05), head lift (17±7 vs 27±11, *P<0.05) and 
Table 3. Premedication, induction, intubation and recovery scores, and other criteria examined 
during recovery in healthy dogs undergoing surgery
Time to administration of  
propofol/fentanyl (min.)
i.v. M +A + D
(0.02 mg +
0.02 mg + 0.5 mg 
per kg, resp.)
i.v. X + A + D
(0.7 mg + 




- 15 3.0 ± 0.6 2.0 ± 0.4
- 10 1.8 ± 0.5 2.4 ± 0.5
- 5 4.2 ± 0.4 3.1 ± 0.3
Induction of  TIVA with i.v. propofol and i.v. fentanyl
Induction score Prior and during the intubation, resp. 1.1 ± 0.3 1.2 ± 0.4
Intubation score 1.0 ± 0.0 1.3 ± 0.5




     – extubation (min.) 13 ± 5 9 ± 3*
     – head lift (min.) 27 ± 11 17 ± 7*
     – sternal recumbency (min.) 39 ± 11 29 ± 11*
     – standing without assistance (min.) 67 ± 7 56 ± 13*
Recovery score 1.8 ± 0.9 1.9 ± 1.0
The propofol/fentanyl infusion preceded with intravenous medetomidine (M), atropine (A) and 
diazepam (D) or intravenous xylazine (X), atropine and diazepam as premedication. The data are 
presented as mean values ± standard deviation. Student’s t-test (*P < 0.05).
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standing without assistance (56±13 vs 67±7, *P<0.05) in the AXD-group. Neither 
whining nor vomiting was seen, but some side effects (drowsiness, ataxia) of  the 
drugs used were found in both groups during the recovery. All dogs included in this 
study recovered from the P/F TIVA without any pharmacological or critical care 
interventions.  
DISCUSSION
It is well known that in dogs the administration of  medetomidine is accompanied 
with cardiorespiratory depression [11, 12]. The PaO2 and PaCO2 were signifi cantly 
decreased in dogs treated with medetomidine within 30 min. after its administration 
[13].  As published by Yamashita et al. [14], medetomidine as well as xylazine have 
the ability to induce cardiovascular depression. On the other hand, Ko et al. [11] 
found that atropine prevents medetomidine induced bradycardia for 50 min. after its 
administration. Moreover, diazepam is a profound sedative and anticonvulsant which 
makes the organism feel less agitated and less tense. For these reasons, we can predict 
that sinus bradycardia (heart rate < 60 beats per min.) was not observed throughout 
the P/F TIVA in both groups probably due to the administration of  atropine in 
the premedication. Vomitus was observed in up to 60% of  dogs within 5 min. after 
administration of  medetomidine (40 μg/kg) or xylazine (2.2 mg/kg). The preanesthetic 
fasting, as well as the reduced doses of  both these drugs in our study, can be the cause 
that nausea or vomitus were not seen in any of  the observed dogs. In accordance 
with our results, the applied dose of  medetomidine (20 μg / kg), in combination with 
atropine and diazepam, is able to induce a deep sedation in dogs [13]. On the other 
hand, the dose of  xylazine 0.7 mg/kg in combination with atropine and diazepam had 
a lower sedative effect. All in all, even a moderate sedation achieved in the AXD-group 
at -5 inhibited the resistance of  dogs to the preoperative procedures. 
In human and canine patients a propofol/fentanyl infusion produces a rapid, pleasant 
and safe anesthesia with only a few untoward side effects with minor hemodynamic 
fl uctuations and with a smooth and swift recovery [5, 15]. De Mulder et al. [16] found 
that the TIVA with propofol and fentanyl provided a stable cardiovascular function in 
vagotomized rabbits after sternotomy. Similarly, in racing dogs undergoing a surgical 
intervention, TIVA maintained with propofol and fentanyl, premedicated only 
with atropine, secures an anesthesia without bradycardia despite some undesirable 
reactions such as leg paddling and whining, seen during the recovery [17]. It has 
been shown that the application of  propofol with fentanyl depresses the ventilation 
of  lungs in humans [18]. On the other hand, Andreoni and Hughes reported stable 
cardiovascular functions in dogs undergoing surgical procedures throughout the 
propofol/fentanyl infusion and a smooth recovery from the anesthesia. A decreased 
HR was recorded from 10 to 30 min. of  anesthesia but their dogs were premedicated 
with intramuscular acepromazine (up to 0.5 mg/kg) and subcutaneous carprofene 
(4 mg/kg) administration. Dzikiti et al. [20] found that a propofol/fentanyl infusion 
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for 90 min. did not require assisted respiration, but recovery was not always smooth 
in goats. In our study, during the propofol/fentanyl infusion, the depression of  the 
cardiovascular system in the AXD-group was delayed for 1 hour when compared with 
the AMD-group. Although, RR started to decrease immediately after the induction of  
TIVA in both groups, the initial values of  RR, as nearly all the studied indices, were 
more preferable in regard to the general anesthesia in the AXD-group. This indicates 
that the protocol used for the premedication can signifi cantly affect the values of  
cardio-pulmonary, hemodynamic and acid-base indices at the onset of  anesthesia and 
thus may infl uence the intraoperative stability of  patients, as well as the length of  the 
recovery period. Contrary to our fi ndings, Bajwa et al. [5] found that propofol/fentanyl 
infusion caused a mild excitation in human patients based on slightly increased RR 
and blood pressure, but a slight respiratory depression was seen during recovery. The 
most evident side effect of  the medetomidine premedication followed with a propofol 
infusion was hypoxemia [21]. During the anesthesia, signs of  slight hypoxia were seen 
in both groups based on acid-base analysis, but rapidly reversible apnea was recorded 
in fi ve dogs only in the AMD-group. 
It can be concluded that xylazine + atropine + diazepam premedication is apparently 
a better option for the premedication of  healthy dogs undergoing prolonged surgical 
procedures using a propofol/fentanyl TIVA, in spite of  the fact that lower sedation 
scores were attained, due to its less marked adverse cardio-respiratory and hemodynamic 
effects in comparison with medetomidine+atropine+diazepam premedication. 
Hypertension as an adverse effect of  this combination could be minimized by using atropine 
due to its ability to cause bradycardia and subsequent hypotension.  Furthermore, apnea 
was not recorded in the AXD-group, thus these dogs breathed spontaneously during 
the entire TIVA, also the time needed to stand without assistance was shorter in these 
dogs when compared to the AXD-group. 
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KARDIORESPIRATORNI I HEMODINAMIČKI EFEKTI 
MEDETOMIDINA ILI KSILAZINA SA ATROPIN I DIAZEPAM 
PREMEDIKACIJOM PRILIKOM INDUKOVANJA TOTALNE 
INTRAVENSKE ANESTEZIJE SA PROPOFOL/FENTANIL-OM 
KOD PASA TOKOM HIRURŠKIH INTERVENCIJA
LIPTÁK Tomáš, CAPÍK Igor, LEDECKÝ Valent, NAGY Oskar, KURICOVÁ 
Mária, TÓTHOVÁ Csilla, MAĎARI Aladár, FARBÁKOVÁ Jana, PETROVIČ 
Vladimír, HORŇÁK Slavomír
Obavljeno je upoređivanje efekata različitih protokola premedikacije koji su pretho-
dili propofol/fentanil TIVA na kardio-respiratorne i hemodinamičke promene kod 
24 psa koji su podeljeni u dve grupe (AMD-grupa: medetomidin, atropin i diazepam; 
AXD-grupa: xylazin, atropin i diazepam). Tokom ogleda, praćene su promenljive kar-
dio-respiratorne vrednosti, acido-bazne vrednosti, kvalitet sedacije, indukcija sedacije, 
intubacija i stepen oporavka od anestezije. 
Značajne promene su uočene u odnosu na pO2 koje su bile povećane u AMD-gru-
pi od 90 (*P<0.05) do 120 minuta (**P<0.01) anestezije. Ovo može da se objasni 
smanjenjem brzine davanja propofol/fentanil TIVA i oksigenacijom koja je izazvana 
naročito dubokom anestezijom koja je uočena od strane anesteziologa, što je vodilo 
pojačanoj ventilaciji i povećanim vrednostima pO2. Zahvaljujući slabijim depresivnim 
efektima ksilazina, u AXD grupi, nivoi pCO2 (*P<0.05) su dostizali željene vrednosti 
tokom prvih 30 minuta, a pH (**P<0.01) vrednosti su bile značajno poboljšane u 
prvih 60 minuta. U prvih 30 minuta anestezije, uočene su značajne razlike u radu srca 
(puls) između grupa pri čemu su vrednosti BP (hipertenzija) bile značajno veće u AXD 
grupi (10 min. ***P<0.001, 30 min. **P<0.01). Ovo ukazuje na mogućnost aplikacije 
atropina samo u slučaju postojanja tendencije razvoja bradikardije koja bi prethodila 
hipotenziji. 
Na osnovu rezultata može da se zaključi da je ksilazin bolja opcija za premedikaciju 
tokom propofol/fentanil TIVA anestezije kod pasa tokom produžene hirurške inter-
vencije, uprkos činjenici da su ustanovljeni niži skorovi sedacije. Ustanovljeni su manje 
značajni neželjeni kardio-respiratorni i hemodinamički efekti ksilazina, kao i kraće 
vreme buđenja u poređenju sa medetomidinom.
